Skip to main content

Year: 2022

Correction: Awilco Drilling PLC: Mandatory notification of trade – primary insiders

Reference is made to the stock exchange announcement by Awilco Drilling PLC (the “Company”) published on 21 December 2022, regarding the successful private placement of new Sponsored Norwegian Depository Receipts in the Company (the “Private Placement”). Certain of the Company’s primary insiders and their close associates have subscribed and been allocated new Sponsored Norwegian Depository Receipts in the Private Placement as further described in the attached forms. Aberdeen, 24 December 2022   For further information please contact: Erik Jacobs, CEO of Awilco Drilling; Tel: +44 1224 737900Cathrine Haavind, Investor Relations of Awilco Drilling; Tel: +47 93 42 84 64, ch@awilcodrilling.com This information is subject to the disclosure requirements in Article 19 of MAR (Regulation (EU) No. 596/2014 on market...

Continue reading

Coherus and Junshi Biosciences Share Update on the FDA Review of the Biologics License Application (BLA) for Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

– FDA has been unable to travel to China to conduct the required site inspection resulting in delayed action on the BLA – – Coherus and Junshi Biosciences are actively engaged in ongoing discussions with the FDA to support the inspections and gain approval of toripalimab for patients with NPC in the U.S. as quickly as possible – SHANGHAI, China, and REDWOOD CITY, Calif., Dec. 24, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) today announced that the companies have not received an action letter from the U.S. Food and Drug Administration (FDA, the Agency) regarding the Biologics License Application (BLA) for toripalimab in combination with chemotherapy as treatment for recurrent or metastatic...

Continue reading

PlantX Announces Filing of Restated Financial Statements for the Year Ended March 31, 2021 and Filing of the Annual Financial Statements for the Year Ended March 31, 2022

VANCOUVER, British Columbia, Dec. 23, 2022 (GLOBE NEWSWIRE) — PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) (“PlantX” or the “Company“), the digital face of the plant-based community, operating a one-stop shop for plant-based products, announces the filing of its restated audited consolidated comparative financial statements and accompanying management’s discussion and analysis for the year ended March 31, 2021 (the “Restated Financial Statements“) and the filing of its annual financial statements for the year ended March 31, 2022 along with its associated management’s discussion and analysis and related officer certifications (the “Annual Filings“). The Restated Financial Statements and the Annual Filings are available under the Company’s SEDAR profile at www.sedar.com. Highlights...

Continue reading

ER Fitch Pty Ltd Acquires Securities of Class 1 Nickel & Technologies Limited

NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES TORONTO, Dec. 23, 2022 (GLOBE NEWSWIRE) — ER Fitch Pty Ltd. ATF Eloise Fitch Family Trust (the “Acquirer”) announces that it has acquired ownership and control of convertible debentures (the “Debentures”) of Class 1 Nickel & Technologies Limited (the “Company” or “Class 1”), effective December 23, 2022 (the “Acquisition”). The Debentures are convertible in accordance with the terms thereof into up to 4,545,454 common shares of the Company (the “Underlying Shares“) at a deemed price of $0.11 per share. The Underlying Shares were issued pursuant to a private placement by the Company and represent approximately 3% of all issued and outstanding common shares of the Company (“Shares”) as of December 23, 2022 on a partially...

Continue reading

Medivolve Announces CAN $1.2 Million Convertible Note Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 23, 2022 (GLOBE NEWSWIRE) — Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; FRA:4NC), a healthcare technology and services company, today announced a secured convertible note financing in the amount of CAN $1.2 million, which includes a CAN $200,000 original issue discount (“OID”). CAN $1.2 Million Secured Convertible Note This investment will be in the form of a secured convertible note (the “Note”) with a face value of CAN $1.4 million, for aggregate gross proceeds to the Company of CAN $1.2 million after deduction of the OID. Cumulative interest on the outstanding principal amount shall be payable at the annual rate of 8.0% per annum. The Note is expected to mature on December 31, 2023 and will be convertible,...

Continue reading

Inscape and HUK 121 Announce Successful Take-Over Bid and Extension of Deposit Period

HOLLAND LANDING, Ontario, Dec. 23, 2022 (GLOBE NEWSWIRE) — Inscape Corporation (“Inscape” or the “Company”) (TSX: INQ), and HUK 121 Limited (the “Offeror”), a subsidiary of Hilco Capital Limited (“Hilco”), are pleased to jointly announce that the Offeror has been successful in its bid to purchase common shares (the “Common Shares”) of Inscape as previously disclosed on October 29, 2022 (the “Offer”). Each of the conditions to the Offer was satisfied or waived by 5:00 p.m. (Toronto time) on December 23, 2022 (the “Initial Expiry Time”). At the Initial Expiry Time, 12,661,625 Common Shares (representing approximately 88.05% of the issued and outstanding Common Shares) (the “Deposited Shares”) were deposited to the Offer and have now been taken up by the Offeror. The aggregate consideration payable for the Deposited Shares is approximately...

Continue reading

Corporate Update: Smart Employee Benefits Inc. Announces Loan from Co-operators

MISSISSAUGA, Ontario, Dec. 23, 2022 (GLOBE NEWSWIRE) — Smart Employee Benefits Inc. (“SEB” or the “Company”) (TSXV: SEB) (OTCQB: SEBFF) a leader in benefits processing solutions and services today announced that Co-operators Financial Services Limited (“Co-operators”), a strategic investor in SEB, has loaned $18,000,000 to SEB (the “Loan”). The Loan is evidenced by a promissory note dated December 23, 2022 (the “Promissory Note”) issued by SEB in favour of Co-operators and bears interest at 15% per annum, with the first payment payable on February 28, 2023, with each subsequent payment to be made on the last business day of every other month thereafter, with a maturity date being the earlier of the date Co-operators makes demand and November 30, 2025. The Loan is secured over the assets of SEB. Proceeds from the Loan were used...

Continue reading

Enservco Corporation Reports 2022 Third Quarter Financial Results

Q3 revenue up 3% YOY to $3.1 million from $3.0 millionQ3 net loss of $3.1 million compared to net income of $0.4 million in the prior year primarily due to the Company receiving $2.0 million in PPP loan forgiveness and $0.7 million in Employee Retention Credits in the third quarter last yearQ3 adjusted EBITDA loss improves to $1.3 million from $1.5 million YOYNine-month revenue increased 35% YOY to $15.1 million from $11.3 millionNine-month net loss reduced to $3.9 million from $5.0 million YOY due primarily to a $4.3 million gain on debt extinguishment in the first quarter of 2022Nine-month adjusted EBITDA loss improved to $2.7 million from $4.1 millionEnservco is now fully current in its SEC filingsLONGMONT, Colo., Dec. 23, 2022 (GLOBE NEWSWIRE) — Enservco Corporation (NYSE American: ENSV), a diversified...

Continue reading

SportsTek Acquisition Corp. Announces Termination of Letter of Intent and Liquidation

NEW YORK, Dec. 23, 2022 (GLOBE NEWSWIRE) — SportsTek Acquisition Corp. (the “Company”) (Nasdaq: SPTK, SPTKU, and SPTKW) announced today that the non-binding letter of intent with Metavisio (d/b/a Thomson Computing), a French company specializing in building, marketing, and selling laptops, whose securities are listed on Euronext Growth in Paris, with respect to a proposed business combination transaction, has been mutually terminated by the parties. In addition, the Company announced today that the board of directors of the Company (the “Board”) has elected to abandon and not implement the extension that was approved by stockholders on December 20, 2022, because despite significant efforts to identify and complete an initial business combination, the Board does not believe that the Company will be able to complete an initial business...

Continue reading

Koios Provides Update on Failure to File Cease Trade Order

DENVER, Dec. 23, 2022 (GLOBE NEWSWIRE) — Koios Beverage Corp. (CSE: FIT; OTC: FITSF) (the “Company” or “Koios”) announces that further to its press release dated December 16, 2022, the British Columbia Securities  Commission (the “BCSC”) has issued a failure to file cease trade order against the Company (“FTFCTO”) which orders that general trading, whether direct or indirect, by any person, of the securities of the Company, cease, which includes trading of the shares of the Company on the Canadian Securities Exchange. The Company is diligently working with its auditors to conclude the filings at the earliest possible time. The delay in completing and filing the Company’s financial statements stems from certain valuation information that was required in connection with the Company’s...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.